Comment from American Pharmacists Association
AnonymousSupportTrade association
Summary: The American Pharmacists Association (APhA) supports the FDA's drug repurposing efforts to accelerate patient access to therapies and suggests adding epinephrine and transplant drugs as priority areas. They urge the FDA to prioritize patient safety, maximize transparency, include pharmacists in discussions, and work with other agencies to ensure reimbursement for pharmacist-provided services.
Dear Deputy Commissioner Graham,
The American Pharmacists Association (APhA) appreciates the opportunity to provide FDA comments on the “Drug Repurposing for Unmet Medical Needs; Request for Information.”
APhA represents pharmacists, student pharmacists, and pharmacy technicians in all practice settings, including but not limited to community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health.
Full comments are attached.